# Foghorn Therapeutics Inc.: Form 8-K, filed Jun 3, 2024

- Company: [Foghorn Therapeutics Inc.](/companies/fhtx.md) (CIK 1822462)
- Form: 8-K
- Filed: 2024-06-03
- Accepted by EDGAR: Jun 3, 2024, 20:02 ET
- Period: 2024-06-03
- Accession: 0001628280-24-026294
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1822462/000162828024026294/fhtx-20240603.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1822462/000162828024026294/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1822462/000162828024026294/fhtx-20240603.htm

Filed Jun 3, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-026294. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.